Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Nolan CM, et al; ATS (American Thoracic Society) Hepato- toxicity of Antituberculosis Therapy Subcommittee. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med 2006; 174: 935-52....
Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Nolan CM, Peloquin CA, Gordin FM, Nunes D, Strader DB, Bernardo J, Venkataramanan R and Sterling TR. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med. 2006;174:...
In addition, as per the same source, for individuals with isolated inhA mutations and rifampicin-resistant tuberculosis (TB), high-dose isoniazid is a helpful addition to second-line TB therapy regimens. This is expected to increase the growth of the segment, thereby propelling the market growth...
BMC Infectious Diseases (2024) 24:681 https://doi.org/10.1186/s12879-024-09367-0 BMC Infectious Diseases RESEARCH Open Access Prevalence of vitamin D deficiency and the effect of vitamin D3 supplementation on response to anti-tuberculosis therapy in patients with extrapulmonary tuberculosis Rasha ...
E. Neutrophils in tuberculosis — first line of defence or booster of disease and targets for host-directed therapy? Pathog. Dis. 74, ftw012 (2016). Article PubMed Google Scholar Eum, S. Y. et al. Neutrophils are the predominant infected phagocytic cells in the airways of patients with ...
Anti-tuberculosis therapy induces a rapid alteration in the microbiota that persists during treatment To address the primary question of this study, we examined the effects of antibiotic treatment on the microbiota composition inMtbinfected mice in a three-way comparison of thenaïve,TBandTB + HRZ...
Conclusions Vitamin D deficiency is prevalent in EPTB patients, in whom, vitamin D supplementation is a useful adjunctive therapy to anti-TB drugs and improves treatment course.Peer Review reports Introduction Tuberculosis (TB) is a major public health threat and a leading cause of morbidity and mo...
An official ATS statement: hepatotoxicity of antituberculosis therapy. Drug-induced liver injury (DILI) is a problem of increasing significance, but has been a long-standing concern in the treatment of tuberculosis (TB) infect... JJ Saukkonen,DL Cohn,RM Jasmer,... - 《American Journal of ...
Tuberculosis (TB) is a global issue, and INH was first reported to be effective for the treatment of TB in 19529. INH remains the first-line drug approved for TB therapy due to its high efficacy. The standard therapies for TB include a combination treatment of INH, rifampicin, pyrazinamide...
An official ATS statement: hepatotoxicity of antituberculosis therapy.Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated ...Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on...